Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Screening for Early Gastric Cancer in Shaanxi Province

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study collect the relevant data of local residents over 20 years old in 11 regions of Shaanxi Province, The basic information of the subjects was collected by filling in the questionnaire, and serum helicobacter pylori antibody detection was completed at the same time. The expert group determined the high-risk population of gastric cancer after comprehensive evaluation. All the high-risk population of gastric cancer without contraindications underwent electronic gastroscopy in the designated hospital after signing the informed consent. By collecting and analyzing data, early gastric cancer screening was completed and a new gastric cancer risk assessment model was established to evaluate the prevalence of dyspepsia, gastroesophageal reflux disease and precancerous lesions in the natural population of Shaanxi Province, as well as helicobacter pylori infection, radical treatment and recurrence rate.

Who May Be Eligible (Plain English)

Who May Qualify: - Local resident over 20 years old. - Obtain verbal willing to sign a consent form of the subject. Who Should NOT Join This Trial: - Refused to participate in this research project. - Questionnaires or serological tests for helicobacter pylori antibodies were not completed. - This study was not completed due to other reasons. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Local resident over 20 years old. * Obtain verbal informed consent of the subject. Exclusion Criteria: * Refused to participate in this research project. * Questionnaires or serological tests for helicobacter pylori antibodies were not completed. * This study was not completed due to other reasons.

Locations (1)

The second affiliated hospital of xi'an jiaotong university
Xi'an, Shaanxi, China